{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:52:13Z","timestamp":1781740333224,"version":"3.54.5"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":51,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"DOI":"10.1186\/s13023-026-04371-w","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:47:11Z","timestamp":1777376831000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Family studies in Gaucher Disease: a key resource for early diagnosis and personalized treatment strategies"],"prefix":"10.1186","volume":"21","author":[{"given":"Martina","family":"Vinci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Giacomarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"D\u2019Errico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Fischetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Immacolata","family":"Tartaglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Tirelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Francofonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Colomba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Duro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1266-0017","authenticated-orcid":false,"given":"Carmela","family":"Zizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"issue":"5","key":"4371_CR1","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.3390\/jcm13051487","volume":"13","author":"M Giacomarra","year":"2024","unstructured":"Giacomarra M, Colomba P, Francofonte D, Zora M, Caocci G, Diomede D, Giuffrida G, Fiori L, Montanari C, Sapuppo A, Scortechini AR, Vitturi N, Duro G, Zizzo C. Gaucher Disease or Acid Sphingomyelinase Deficiency? The Importance of Differential Diagnosis. J Clin Med. 2024;13(5):1487. https:\/\/doi.org\/10.3390\/jcm13051487. PMID: 38592326; PMCID: PMC10932152.","journal-title":"J Clin Med"},{"issue":"8","key":"4371_CR2","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.3390\/ijms26083918","volume":"26","author":"M Anania","year":"2025","unstructured":"Anania M, Giacomarra M, D\u2019Errico A, Marano M, Tartaglione I, Spada M, Pagliardini V, De Paolis MR, Giuffrida G, Duro G, Di Chiara T, Francofonte D, Marsana EM, Colomba P, Duro G, Zizzo C. Identification of Novel Mutations in Patients Affected by Gaucher Disease. Int J Mol Sci. 2025;26(8):3918. https:\/\/doi.org\/10.3390\/ijms26083918. PMID: 40332757; PMCID: PMC12028185.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4371_CR3","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3390\/biomedicines13040973","volume":"13","author":"M Vinci","year":"2025","unstructured":"Vinci M, Zizzo C, Moschetti M, Giacomarra M, Anania M, Duro G, Di Chiara T, Russo M, Messina E, Colomba P, Duro G. Multiplex Ligation Probe Amplification and Sanger Sequencing: Light and Shade in the Diagnosis of Lysosomal Storage Disorders. Biomedicines. 2025;13(4):973. https:\/\/doi.org\/10.3390\/biomedicines13040973. PMID: 40299551; PMCID: PMC12024813.","journal-title":"Biomedicines"},{"issue":"2","key":"4371_CR4","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3390\/ijms18020441","volume":"18","author":"J Stirnemann","year":"2017","unstructured":"Stirnemann J, Belmatoug N, Camou F, Serratrice C, Froissart R, Caillaud C, Levade T, Astudillo L, Serratrice J, Brassier A, Rose C, Billette de Villemeur T, Berger MG. A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments. Int J Mol Sci. 2017;18(2):441. https:\/\/doi.org\/10.3390\/ijms18020441. PMID: 28218669; PMCID: PMC5343975.","journal-title":"Int J Mol Sci"},{"key":"4371_CR5","doi-asserted-by":"publisher","unstructured":"Levin M, Pleskova I, Pastores GM. Gaucher disease: Genetics, diagnosis and management. Drugs Today (Barc). 2001;37(4):257\u2013264. https:\/\/doi.org\/10.1358\/dot.2001.37.4.620591. PMID: 12768226.","DOI":"10.1358\/dot.2001.37.4.620591"},{"issue":"2","key":"4371_CR6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ymgme.2020.12.295","volume":"132","author":"NJ Weinreb","year":"2021","unstructured":"Weinreb NJ, Camelo JS Jr, Charrow J, McClain MR, Mistry P, Belmatoug N. International Collaborative Gaucher Group (ICGG) Gaucher Registry (NCT00358943) investigators. Gaucher disease type 1 patients from the ICGG Gaucher Registry sustain initial clinical improvements during twenty years of imiglucerase treatment. Mol Genet Metab. 2021;132(2):100\u201311. Epub 2021 Jan 8. PMID: 33485799.","journal-title":"Mol Genet Metab"},{"key":"4371_CR7","doi-asserted-by":"publisher","unstructured":"Charrow J, Andersson HC, Kaplan P, Kolodny EH, Mistry P, Pastores G, Rosenbloom BE, Scott CR, Wappner RS, Weinreb NJ, Zimran A. The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease. Arch Intern Med. 2000;160(18):2835-43. https:\/\/doi.org\/10.1001\/archinte.160.18.2835. PMID: 11025794.","DOI":"10.1001\/archinte.160.18.2835"},{"key":"4371_CR8","doi-asserted-by":"publisher","unstructured":"Sidransky E. Gaucher disease: complexity in a simple disorder. Mol Genet Metab. 2004 Sep-Oct;83(1\u20132):6\u201315. https:\/\/doi.org\/10.1016\/j.ymgme.2004.08.015 PMID: 15464415.","DOI":"10.1016\/j.ymgme.2004.08.015"},{"issue":"77","key":"4371_CR9","first-page":"273","volume":"14","author":"E Sidransky","year":"2012","unstructured":"Sidransky E. Gaucher disease: insights from a rare Mendelian disorder. Discov Med. 2012;14(77):273\u201381. PMID: 23114583; PMCID: PMC4141347.","journal-title":"Discov Med"},{"issue":"4","key":"4371_CR10","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1007\/s13760-024-02493-1","volume":"124","author":"W Zhong","year":"2024","unstructured":"Zhong W, Li D, Fei Y, Hong P. A review of type 3 Gaucher disease: unique neurological manifestations and advances in treatment. Acta Neurol Belg. 2024;124(4):1213\u201323. https:\/\/doi.org\/10.1007\/s13760-024-02493-1. Epub 2024 Feb 28. PMID: 38413480.","journal-title":"Acta Neurol Belg"},{"issue":"2","key":"4371_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.revmed.2022.11.012","volume":"44","author":"Y Perez","year":"2023","unstructured":"Perez Y, Belmatoug N, Bengherbia M, Yousfi K, Lioger B. [Misdiagnosis of Gaucher disease in real life: Retrospective study of the French Gaucher\u2019s disease registry]. Rev Med Interne. 2023;44(2):55\u201361. Epub 2023 Jan 18. PMID: 36669934.","journal-title":"Rev Med Interne"},{"key":"4371_CR12","doi-asserted-by":"publisher","unstructured":"Mistry PK, Sadan S, Yang R, Yee J, Yang M. Consequences of diagnostic delays in type 1 Gaucher disease: the need for greater awareness among hematologists-oncologists and an opportunity for early diagnosis and intervention. Am J Hematol. 2007;82(8):697\u2013701. https:\/\/doi.org\/10.1002\/ajh.20908. PMID: 17492645.","DOI":"10.1002\/ajh.20908"},{"issue":"1","key":"4371_CR13","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/ajh.21888","volume":"86","author":"PK Mistry","year":"2011","unstructured":"Mistry PK, Cappellini MD, Lukina E, Ozsan H, Mach Pascual S, Rosenbaum H, Helena Solano M, Spigelman Z, Villarrubia J, Watman NP, Massenkeil G. A reappraisal of Gaucher disease-diagnosis and disease management algorithms. Am J Hematol. 2011;86(1):110\u20135. https:\/\/doi.org\/10.1002\/ajh.21888. PMID: 21080341; PMCID: PMC3058841.","journal-title":"Am J Hematol"},{"key":"4371_CR14","unstructured":"Trindade e Silva LP, Silva H, Cabrera H. Doen\u00e7a de Gaucher [Gaucher disease]. Acta Med Port. 2007 Mar-Apr;20(2):175-8. Portuguese. Epub 2007 Jun 11. PMID: 17868524."},{"issue":"1","key":"4371_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13023-023-02623-7","volume":"18","author":"G Giuffrida","year":"2023","unstructured":"Giuffrida G, Markovic U, Condorelli A, Calafiore V, Nicolosi D, Calagna M, Grasso S, Ragusa MTV, Gentile J, Napolitano M. Glucosylsphingosine (Lyso-Gb1) as a reliable biomarker in Gaucher disease: a narrative review. Orphanet J Rare Dis. 2023;18(1):27. https:\/\/doi.org\/10.1186\/s13023-023-02623-7. PMID: 36782327; PMCID: PMC9926807.","journal-title":"Orphanet J Rare Dis"},{"issue":"19","key":"4371_CR16","doi-asserted-by":"publisher","first-page":"7159","DOI":"10.3390\/ijms21197159","volume":"21","author":"S Revel-Vilk","year":"2020","unstructured":"Revel-Vilk S, Fuller M, Zimran A. Value of Glucosylsphingosine (Lyso-Gb1) as a Biomarker in Gaucher Disease: A Systematic Literature Review. Int J Mol Sci. 2020;21(19):7159. https:\/\/doi.org\/10.3390\/ijms21197159. PMID: 32998334; PMCID: PMC7584006.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4371_CR17","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1002\/jimd.12192","volume":"43","author":"JT Saville","year":"2020","unstructured":"Saville JT, McDermott BK, Chin SJ, Fletcher JM, Fuller M. Expanding the clinical utility of glucosylsphingosine for Gaucher disease. J Inherit Metab Dis. 2020;43(3):558\u201363. https:\/\/doi.org\/10.1002\/jimd.12192. Epub 2019 Nov 26. PMID: 31707742.","journal-title":"J Inherit Metab Dis"},{"issue":"16","key":"4371_CR18","doi-asserted-by":"publisher","first-page":"e118","DOI":"10.1182\/blood-2011-05-352971","volume":"118","author":"N Dekker","year":"2011","unstructured":"Dekker N, van Dussen L, Hollak CE, Overkleeft H, Scheij S, Ghauharali K, van Breemen MJ, Ferraz MJ, Groener JE, Maas M, Wijburg FA, Speijer D, Tylki-Szymanska A, Mistry PK, Boot RG, Aerts JM. Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response. Blood. 2011;118(16):e118\u201327. https:\/\/doi.org\/10.1182\/blood-2011-05-352971. Epub 2011 Aug 25. PMID: 21868580; PMCID: PMC3685900.","journal-title":"Blood"},{"issue":"12","key":"4371_CR19","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.3390\/ijms20123033","volume":"20","author":"N Hurvitz","year":"2019","unstructured":"Hurvitz N, Dinur T, Becker-Cohen M, Cozma C, Hovakimyan M, Oppermann S, Demuth L, Rolfs A, Abramov A, Zimran A, Revel-Vilk S. Glucosylsphingosine (lyso-Gb1) as a Biomarker for Monitoring Treated and Untreated Children with Gaucher Disease. Int J Mol Sci. 2019;20(12):3033. https:\/\/doi.org\/10.3390\/ijms20123033. PMID: 31234327; PMCID: PMC6627663.","journal-title":"Int J Mol Sci"},{"key":"4371_CR20","volume-title":"GeneReviews\u00ae [Internet]","author":"DA Hughes","year":"2000","unstructured":"Hughes DA, Pastores GM. Gaucher Disease. 2000 Jul 27 [updated 2023 Dec 7]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993\u20132025. PMID: 20301446."},{"issue":"4","key":"4371_CR21","doi-asserted-by":"publisher","first-page":"364","DOI":"10.3390\/cells8040364","volume":"8","author":"GM Riboldi","year":"2019","unstructured":"Riboldi GM, Di Fonzo AB. GBA, Gaucher disease, and Parkinson\u2019s disease: from genetic to clinic to new therapeutic approaches. Cells. 2019;8(4):364. https:\/\/doi.org\/10.3390\/cells8040364. PMID: 31010158; PMCID: PMC6523296.","journal-title":"Cells"},{"key":"4371_CR22","doi-asserted-by":"publisher","first-page":"107023","DOI":"10.1016\/j.parkreldis.2024.107023","volume":"124","author":"M Marano","year":"2024","unstructured":"Marano M, Zizzo C, Malaguti MC, Bacchin R, Cavallieri F, De Micco R, Spagnolo F, Bentivoglio AR, Schirinzi T, Bovenzi R, Ramat S, Erro R, Sorrentino C, Sucapane P, Pilotto A, Lupini A, Magliozzi A, Di Vico I, Carecchio M, Bonato G, Cilia R, Colucci F, Tamma F, Caputo E, Mostile G, Arabia G, Modugno N, Zibetti M, Ceravolo MG, Tambasco N, Cossu G, Valzania F, Manganotti P, Di Lazzaro V, Zappia M, Fabbrini G, Tinazzi M, Tessitore A, Duro G, Di Fonzo A. Increased glucosylsphingosine levels and Gaucher disease in GBA1-associated Parkinson\u2019s disease. Parkinsonism Relat Disord. 2024;124:107023. https:\/\/doi.org\/10.1016\/j.parkreldis.2024.107023. Epub 2024 Jun 1. PMID: 38843618.","journal-title":"Parkinsonism Relat Disord"},{"key":"4371_CR23","doi-asserted-by":"publisher","unstructured":"Chamoles NA, Blanco M, Gaggioli D. Fabry disease: enzymatic diagnosis in dried blood spots on filter paper. Clin Chim Acta. 2001;308(1\u20132):195-6. https:\/\/doi.org\/10.1016\/s0009-8981(01)00478-8. PMID: 11432396.","DOI":"10.1016\/s0009-8981(01)00478-8"},{"key":"4371_CR24","doi-asserted-by":"publisher","unstructured":"Polo G, Burlina AP, Kolamunnage TB, Zampieri M, Dionisi-Vici C, Strisciuglio P, Zaninotto M, Plebani M, Burlina AB. Diagnosis of sphingolipidoses: a new simultaneous measurement of lysosphingolipids by LC-MS\/MS. Clin Chem Lab Med. 2017;55(3):403\u2013414. https:\/\/doi.org\/10.1515\/cclm-2016-0340. PMID: 27533120.","DOI":"10.1515\/cclm-2016-0340"},{"key":"4371_CR25","doi-asserted-by":"publisher","unstructured":"Tang C, Jia X, Tang F, Liu S, Jiang X, Zhao X, Sheng H, Peng M, Liu L, Huang Y. Detection of glucosylsphingosine in dried blood spots for diagnosis of Gaucher disease by LC-MS\/MS. Clin Biochem. 2021;87:79\u201384. https:\/\/doi.org\/10.1016\/j.clinbiochem.2020.10.011. Epub 2020 Nov 11. PMID: 33188770.","DOI":"10.1016\/j.clinbiochem.2020.10.011"},{"issue":"2","key":"4371_CR26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/ijns5020024","volume":"5","author":"AB Burlina","year":"2019","unstructured":"Burlina AB, Polo G, Rubert L, Gueraldi D, Cazzorla C, Duro G, Salviati L, Burlina AP. Implementation of Second-Tier Tests in Newborn Screening for Lysosomal Disorders in North Eastern Italy. Int J Neonatal Screen. 2019;5(2):24. https:\/\/doi.org\/10.3390\/ijns5020024. PMID: 33072983; PMCID: PMC7510225.","journal-title":"Int J Neonatal Screen"},{"key":"4371_CR27","doi-asserted-by":"publisher","unstructured":"Polo G, Burlina AP, Ranieri E, Colucci F, Rubert L, Pascarella A, Duro G, Tummolo A, Padoan A, Plebani M, Burlina AB. Plasma and dried blood spot lysosphingolipids for the diagnosis of different sphingolipidoses: a comparative study. Clin Chem Lab Med. 2019;57(12):1863\u20131874. https:\/\/doi.org\/10.1515\/cclm-2018-1301. PMID: 31091195.","DOI":"10.1515\/cclm-2018-1301"},{"issue":"2","key":"4371_CR28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s10545-017-0098-3","volume":"41","author":"AB Burlina","year":"2018","unstructured":"Burlina AB, Polo G, Salviati L, Duro G, Zizzo C, Dardis A, Bembi B, Cazzorla C, Rubert L, Zordan R, Desnick RJ, Burlina AP. Newborn screening for lysosomal storage disorders by tandem mass spectrometry in North East Italy. J Inherit Metab Dis. 2018;41(2):209\u201319. https:\/\/doi.org\/10.1007\/s10545-017-0098-3. Epub 2017 Nov 15. PMID: 29143201.","journal-title":"J Inherit Metab Dis"},{"key":"4371_CR29","doi-asserted-by":"publisher","unstructured":"Guggenbuhl P, Grosbois B, Chal\u00e8s G. Gaucher disease. Joint Bone Spine. 2008;75(2):116\u2009\u2013\u200924. https:\/\/doi.org\/10.1016\/j.jbspin.2007.06.006. Epub 2007 Aug 31. PMID: 17996473.","DOI":"10.1016\/j.jbspin.2007.06.006"},{"key":"4371_CR30","doi-asserted-by":"publisher","unstructured":"Pasmanik-Chor M, Laadan S, Elroy-Stein O, Zimran A, Abrahamov A, Gatt S, Horowitz M. The glucocerebrosidase D409H mutation in Gaucher disease. Biochem Mol Med. 1996;59(2):125\u2009\u2013\u200933. https:\/\/doi.org\/10.1006\/bmme.1996.0077. PMID: 8986634.","DOI":"10.1006\/bmme.1996.0077"},{"key":"4371_CR31","first-page":"100895","volume":"32","author":"N Ridova","year":"2022","unstructured":"Ridova N, Trajkova S, Chonevska B, Stojanoski Z, Ivanovski M, Popova-Labachevska M, Stojanovska-Jakimovska S, Filipche V, Sofijanova A, Panovska-Stavridis I. Gaucher disease in North Macedonia: Unexpected prevalence of the N370S GBA1 allele with attenuated disease expression. Mol Genet Metab Rep. 2022;32:100895. PMID: 35845720; PMCID: PMC9283653.","journal-title":"Mol Genet Metab Rep"},{"issue":"9","key":"4371_CR32","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1111\/jnc.16114","volume":"168","author":"G Onal","year":"2024","unstructured":"Onal G, Yal\u00e7\u0131n-\u00c7akmakl\u0131 G, \u00d6z\u00e7elik CE, Boussaad I, \u015eeker U\u00d6\u015e, Fernandes HJR, Demir H, Kr\u00fcger R, Elibol B, D\u00f6kmeci S, Salman MM. Variant-specific effects of GBA1 mutations on dopaminergic neuron proteostasis. J Neurochem. 2024;168(9):2543\u201360. https:\/\/doi.org\/10.1111\/jnc.16114. Epub 2024 Apr 20. PMID: 38641924; PMCID: PMC11898552.","journal-title":"J Neurochem"},{"key":"4371_CR33","doi-asserted-by":"publisher","unstructured":"Michelakakis H, Skardoutsou A, Mathioudakis J, Moraitou M, Dimitriou E, Voudris C, Karpathios T. Early-onset severe neurological involvement and D409H homozygosity in Gaucher disease: outcome of enzyme replacement therapy. Blood Cells Mol Dis. 2002 Jan-Feb;28(1):1\u20134. https:\/\/doi.org\/10.1006\/bcmd.2001.0477. PMID: 11814305.","DOI":"10.1006\/bcmd.2001.0477"},{"key":"4371_CR34","doi-asserted-by":"publisher","unstructured":"Vilageliu L, Grinberg D. Involvement of Gaucher disease mutations in Parkinson disease. Curr Protein Pept Sci. 2017;18(7):758\u2013764. https:\/\/doi.org\/10.2174\/1389203717666160311115956. PMID: 26965692.","DOI":"10.2174\/1389203717666160311115956"},{"issue":"7","key":"4371_CR35","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1007\/s00415-024-12439-5","volume":"271","author":"G Imbalzano","year":"2024","unstructured":"Imbalzano G, Ledda C, Romagnolo A, Covolo A, Lopiano L, Artusi CA. Neurological symptoms in adults with Gaucher disease: a systematic review. J Neurol. 2024;271(7):3897\u2013907. https:\/\/doi.org\/10.1007\/s00415-024-12439-5. Epub 2024 May 21. PMID: 38771384; PMCID: PMC11233309.","journal-title":"J Neurol"},{"issue":"3","key":"4371_CR36","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s10545-011-9307-7","volume":"34","author":"M Balwani","year":"2011","unstructured":"Balwani M, Grace ME, Desnick RJ. Gaucher disease: when molecular testing and clinical presentation disagree -the novel c.1226A\u2009>\u2009G(p.N370S)--RecNcil allele. J Inherit Metab Dis. 2011;34(3):789\u201393. https:\/\/doi.org\/10.1007\/s10545-011-9307-7. Epub 2011 Mar 23. PMID: 21431620; PMCID: PMC3269069.","journal-title":"J Inherit Metab Dis"},{"key":"4371_CR37","doi-asserted-by":"publisher","unstructured":"Zimran A, Horowitz M. RecTL: a complex allele of the glucocerebrosidase gene associated with a mild clinical course of Gaucher disease. Am J Med Genet. 1994;50(1):74\u2009\u2013\u20098. https:\/\/doi.org\/10.1002\/ajmg.1320500116. PMID: 8160756.","DOI":"10.1002\/ajmg.1320500116"},{"key":"4371_CR38","doi-asserted-by":"crossref","unstructured":"Stone DL, Tayebi N, Orvisky E, Stubblefield B, Madike V, Sidransky E. Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease. Hum Mutat. 2000;15(2):181-8. https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/(SICI)1098-1004(200002)15:2%3C181::AID-HUMU7%3E3.0.CO;2-S. PMID: 10649495.","DOI":"10.1002\/(SICI)1098-1004(200002)15:2<181::AID-HUMU7>3.0.CO;2-S"},{"issue":"5","key":"4371_CR39","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1399-0004.2009.01163.x","volume":"75","author":"J Vithayathil","year":"2009","unstructured":"Vithayathil J, Gibney G, Baxevanis AD, Stubblefield BK, Sidransky E, Tayebi N. Glucocerebrosidase mutation H255Q appears to be exclusively in cis with D409H: structural implications. Clin Genet. 2009;75(5):503\u20134. https:\/\/doi.org\/10.1111\/j.1399-0004.2009.01163.x. PMID: 19459886; PMCID: PMC3341623.","journal-title":"Clin Genet"},{"key":"4371_CR40","doi-asserted-by":"publisher","unstructured":"Santamaria R, Michelakakis H, Moraitou M, Dimitriou E, Dominissini S, Grossi S, S\u00e1nchez-Oll\u00e9 G, Chab\u00e1s A, Pittis MG, Filocamo M, Vilageliu L, Grinberg D. Haplotype analysis suggests a single Balkan origin for the Gaucher disease [D409H; H255Q] double mutant allele. Hum Mutat. 2008;29(6):E58-67. https:\/\/doi.org\/10.1002\/humu.20776. PMID: 18429048.","DOI":"10.1002\/humu.20776"},{"issue":"2","key":"4371_CR41","first-page":"158","volume":"2","author":"R Kauli","year":"2000","unstructured":"Kauli R, Zaizov R, Lazar L, Pertzelan A, Laron Z, Galatzer A, Phillip M, Yaniv Y, Cohen IJ. Delayed growth and puberty in patients with Gaucher disease type 1: natural history and effect of splenectomy and\/or enzyme replacement therapy. Isr Med Assoc J. 2000;2(2):158\u201363. PMID: 10804944.","journal-title":"Isr Med Assoc J"},{"issue":"4","key":"4371_CR42","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1136\/jmg.23.4.319","volume":"23","author":"J Zlotogora","year":"1986","unstructured":"Zlotogora J, Zaizov R, Klibansky C, Matoth Y, Bach G, Cohen T. Genetic heterogeneity in Gaucher disease. J Med Genet. 1986;23(4):319\u201322. https:\/\/doi.org\/10.1136\/jmg.23.4.319. PMID: 3746831; PMCID: PMC1049697.","journal-title":"J Med Genet"},{"issue":"3","key":"4371_CR43","doi-asserted-by":"publisher","first-page":"e70038","DOI":"10.1002\/jimd.70038","volume":"48","author":"MR Moio","year":"2025","unstructured":"Moio MR, Milke JC, Moutapam-Ngamby-Adriaansen Y, Alberti AM, Gernay M, Sch\u00fctz EA, Schwartz IVD, Maillot F. Diagnosis of Inherited Metabolic Disease in Older Patients: A Systematic Literature Review. J Inherit Metab Dis. 2025;48(3):e70038. https:\/\/doi.org\/10.1002\/jimd.70038. PMID: 40406818; PMCID: PMC12100460.","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"4371_CR44","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1159\/000489251","volume":"139","author":"S Mariani","year":"2018","unstructured":"Mariani S, Palumbo G, Cardarelli L, Santopietro M, Fo\u00e0 R, Giona F. Gaucher Disease and Myelofibrosis: A Combined Disease or a Misdiagnosis? Acta Haematol. 2018;139(4):240\u20132. https:\/\/doi.org\/10.1159\/000489251. Epub 2018 Jun 26. PMID: 29945135.","journal-title":"Acta Haematol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04371-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04371-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04371-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:08:28Z","timestamp":1781737708000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04371-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4371"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04371-w","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"9 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Hospital Ethics Committee of the University of Palermo on 14 September 2022 with approval code number 08\/2022.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent statement"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"225"}}